Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
After an Alzheimer’s diagnosis, you should ask your doctor three essential questions first: What stage of the disease am I in right now, and what does that mean for how I’ll function over the next months and years? What treatment options are available to me, and how might they slow or manage my symptoms? Who should I talk to about legal documents, finances, and my care plan as the disease progresses? These three questions form the foundation for everything else you need to know, because they address the present reality, your medical options, and your future planning simultaneously. A diagnosis can feel overwhelming, but the specificity of your questions determines the usefulness of your answers. For example, someone diagnosed with early-stage Alzheimer’s who learns they’re still years away from needing full-time care may prioritize questions about continuing work or driving safety, while someone in middle-stage disease needs to focus immediately on care arrangements and cognitive support strategies. The doctor’s office visit after diagnosis is not the only conversation you’ll have, but it’s the one where you gather the framework for all the others.
Table of Contents
- What Stage Am I In, and What Does That Mean for My Daily Life?
- What Medications and Treatments Can Help, and What Are Their Actual Limitations?
- What Legal and Financial Decisions Should I Make Now While I Still Have Full Decision-Making Capacity?
- What Kind of Care Support Will I Need, and When Should I Plan for It?
- What Screening and Follow-up Should I Have to Catch Other Health Problems?
- How Do I Tell My Employer, Family, and Friends About This Diagnosis?
- What’s the Difference Between Alzheimer’s and Normal Age-Related Memory Changes?
What Stage Am I In, and What Does That Mean for My Daily Life?
Alzheimer’s progresses through three general stages—early (mild), middle (moderate), and late (severe)—but the actual experience varies widely from person to person. In early-stage disease, memory lapses might include forgetting appointments or repeating conversations you had days ago, but you can still manage finances, cook, and handle basic self-care.
Ask your doctor specifically: Am I early-stage, middle-stage, or late-stage? How long has the disease likely been developing before this diagnosis? Will I be able to continue working, and if so, for how long? The timing of a diagnosis matters because some people are diagnosed early while they still have years of relatively independent function ahead, while others are diagnosed only after cognitive decline has become obvious to family members or colleagues. Someone diagnosed at 62 with early-stage disease faces a different conversation with their employer than someone diagnosed at 78 with middle-stage disease who can no longer drive safely. Ask about the specific symptoms you’ve already experienced and whether they’re expected to worsen in a particular pattern or unpredictably.
What Medications and Treatments Can Help, and What Are Their Actual Limitations?
Several medications exist for Alzheimer’s disease—including cholinesterase inhibitors like donepezil and newer monoclonal antibodies like aducanumab and lecanemab. Ask your doctor: Which medications might be appropriate for my stage, and what’s the realistic benefit? How long do these medications typically slow cognitive decline—are we talking about months or years? What are the side effects, and how will we monitor whether the medication is working? One critical limitation to understand: these medications slow cognitive decline in some people, but they don’t stop the disease or reverse damage that’s already occurred. A medication that delays cognitive decline by six months is meaningful for someone in early-stage disease, but the disease will still progress.
Additionally, newer medications like lecanemab require regular infusions and blood tests to monitor for amyloid-related imaging abnormalities (ARIA), which can cause brain swelling or microhemorrhages. Not everyone is a candidate, and some people stop treatment because the side effects outweigh the modest cognitive benefit. Ask whether you’ll be retested periodically to see if the medication is still appropriate for you.
What Legal and Financial Decisions Should I Make Now While I Still Have Full Decision-Making Capacity?
This question often gets delayed because it feels premature or depressing, but it’s one of the most important. Ask your doctor for a referral to an elder law attorney or financial advisor, and ask them specifically: Should I establish a durable power of attorney for healthcare and finances? Do I need to create or update a living will? Should I document my wishes about future care in an advance directive? For example, a 65-year-old diagnosed with early-stage Alzheimer’s who doesn’t address these documents may spend the next 3-5 years in a state where they can still understand complex information but gradually become unable to sign legal documents or make medical decisions.
If they wait until middle-stage disease to try to sign a power of attorney, an attorney might question whether they truly understand the implications, and the document could be challenged. In contrast, if the documents are in place from the beginning, the designated person can step in smoothly as needed. Ask whether your state has specific requirements for capacity assessments when signing advance directives.
What Kind of Care Support Will I Need, and When Should I Plan for It?
Ask your doctor or a social worker: What care will I likely need as my disease progresses—will I need help with medications, bathing, dressing, or round-the-clock supervision? Should I plan for in-home care, assisted living, or memory care in a facility? How much does care typically cost, and what does insurance or Medicare cover? If a family member will be a primary caregiver, what support and respite care do they need? Many families assume they’ll provide all care themselves but don’t anticipate the emotional and physical toll. Comparing scenarios is helpful: a person might plan to remain at home with family caregiving through middle-stage disease, but not anticipate that late-stage Alzheimer’s involves nighttime wandering, loss of bladder control, and inability to recognize family members—demands that often exceed what a family caregiver alone can manage.
Some people plan for facility care from the start because they want to avoid becoming a burden on family. Others prefer to stay home as long as possible and accept greater family involvement. There’s no universal right answer, but the planning conversation needs to happen when you can still articulate your preferences.
What Screening and Follow-up Should I Have to Catch Other Health Problems?
Alzheimer’s disease doesn’t exist in isolation. Ask your doctor: Will I still need my regular cancer screenings, heart health checks, and other preventive care? How often should I see you for Alzheimer’s-specific follow-up, and what will those visits include? What warning signs should prompt an urgent appointment—infection, behavioral changes, or severe confusion? A common mistake is assuming that once someone has an Alzheimer’s diagnosis, other health issues are less important.
In reality, an infection like a urinary tract infection can temporarily worsen confusion in an Alzheimer’s patient much more dramatically than in someone without cognitive decline, so detecting and treating infections promptly matters significantly. Similarly, someone with early-stage Alzheimer’s still needs blood pressure management and cholesterol screening because cardiovascular health affects brain blood flow. Ask about medication interactions between Alzheimer’s medications and other drugs you take, and whether your doctor monitors kidney and liver function regularly since some Alzheimer’s medications affect these organs.
How Do I Tell My Employer, Family, and Friends About This Diagnosis?
Ask your doctor whether they recommend disclosing the diagnosis at work immediately or waiting until it affects your job performance. Consider talking to your company’s human resources department about reasonable accommodations—some people with early-stage Alzheimer’s benefit from simplified task lists, written reminders, or adjusted schedules. For family, honesty is generally better than avoidance, because they’ll likely notice memory problems anyway and may interpret silence as secrecy.
When telling adult children or parents about the diagnosis, be specific about what you’re experiencing and what you still do well. For example, saying “I have Alzheimer’s disease” means very different things to different people—some imagine complete loss of memory within months, while others think of the very slow decline they watched in a parent. Clarifying “I’m in the early stage and my main symptom right now is difficulty remembering appointments and recent conversations, but my long-term memory is intact” sets expectations more realistically. Tell close family the name of your neurologist and key medical information so they can support you if your condition changes.
What’s the Difference Between Alzheimer’s and Normal Age-Related Memory Changes?
Ask your doctor to clarify: What findings on my imaging or cognitive tests confirmed the Alzheimer’s diagnosis? Normal aging involves occasionally forgetting where you put your keys or what you had for lunch; Alzheimer’s involves forgetting an appointment you made this morning, even when reminded. Alzheimer’s also typically affects other cognitive functions beyond memory—difficulty with language, judgment, problem-solving, or visual-spatial skills. Your neurologist should explain whether the diagnosis was made based on cognitive testing, imaging findings (like PET scans showing amyloid or tau), genetic markers, or a combination.
Understanding the specific evidence for your diagnosis is important because it affects prognosis. Someone with clear amyloid and tau findings on a PET scan is more likely to have the pathological Alzheimer’s disease than someone whose diagnosis is based primarily on cognitive testing alone. Ask whether you’ll have follow-up imaging or testing to monitor whether medications are slowing the accumulation of amyloid and tau in your brain, and how frequently that monitoring will occur.
- —
